"Tailored junior capital
for the mid-market"
LaborMed
Funds advised by Syntaxis provided mezzanine capital for the acquisition by Advent International of LaborMed, the largest independent generics manufacturer in Romania. Founded in 1991, Labor Med’s initial focus was on building its portfolio on cardiovascular and central nervous systems treatments, but has since transformed itself into a speciality pharmaceutical and consumer healthcare business offering a mix of high profile OTC branded products as well as modern prescription products across the key Central European markets. The Company’s proprietary distribution network, its class-leading research and its state-of-the art production all position LaborMed well within the markets it serves
